Delivery Order SPE2DB20D3303-SPE2DB25FA4GH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,894.36 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. The contract, which was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order under a competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $5,286.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24ml pens on September 8, 2025, with completion scheduled for September 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $5,915.41 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections. This is a firm fixed price, competitively awarded contract with a completion date of August 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract contains no set-aside designation, reflecting open competition among qualified vendors....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $16,561.84 for the supply of Teriparatide 560mcg/2.24ml pens. This firm fixed price, competitively awarded contract was issued by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, with an ultimate completion date of July 24, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, valued at $22,413.75 under a firm fixed-price contract. The award was made on May 27, 2025, with an ultimate completion date of May 28, 2025, and represents a competitive, non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $41,615.46 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24mL pen injections. The contract, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $90,086.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Teriparatide 560 mcg/2.24 ml pens with a completion date of June 4, 2025. This contract utilizes no set-aside designation and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement valued through December 2026. The...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 6, 2025, for the supply of Teriparatide 560 mcg/2.24 mL pen injections, valued at $13,541.58. This firm fixed-price, competitively awarded contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. The delivery order carries no set-aside designation and represents a routine...
- The Defense Logistics Agency awarded a $26,852.75 delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. This contract represents a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid hormone used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for teriparatide 560 mcg/2.24 mL pen injections, valued at $5,592.67 with a firm fixed price structure. The award, issued on August 22, 2025, with completion targeted for August 25, 2025, represents a non-set-aside competitive award for pharmaceutical supply fulfillment. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA4GHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,997.91 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 30, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement. The company maintains an extensive portfolio of competitively awarded contracts with the DLA Medical Supply Chain, supplying specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. This delivery order for Teriparatide, an osteoporosis treatment medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements for Department of Defense healthcare systems, with performance occurring at the company's corporate office location in Conshohocken.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 9/29/25 |